Total 283
¹øÈ£ Á¦   ¸ñ ±Û¾´ÀÌ ³¯Â¥ Á¶È¸
°øÁö 2024³â °æ³²³»°úÀÇ»çȸ Ãß°èÇмú´ëȸ ¾È³» Ãѹ«ÀÌÁö¿µ 2024-07-29 727
°øÁö 2024³â °æ³²³»°úÀÇ»çȸ Ãá°èÇмú´ëȸ ¾È³» Ãѹ«ÀÌ»ç 2024-02-13 1055
148 Ãß°èÇмú´ëȸ »çÀüµî·ÏÀÚ ÇöȲ(9¿ù4ÀÏ¿ÀÈÄ4½Ã±îÁö) ±è¼º¿í 2014-09-04 805
147 Ãß°èÇмú´ëȸ »çÀüµî·ÏÀÚ ¸í´Ü(9¿ù3ÀÏÇÑ) ±è¼º¿í 2014-09-03 797
146 2014 Ãß°èÇмú µî·Ï ¹æ¹ý ÃÖ°í°ü¸®ÀÚ 2014-09-03 803
145 Ãß°èÇмú´ëȸ »çÀüµî·ÏÀÚ ¸í´Ü(9¿ù2ÀÏÇÑ) ±è¼º¿í 2014-09-02 824
144 2014³â Ãß°èÇмú´ëȸ »çÀüµî·Ï ¸í´Ü(8¿ù 31ÀÏ ÇÑ) ±è¼º¿í 2014-08-31 822
143 SGLT-2 inhibitor°è ¾àÁ¦ÀÇ ±Þ¿©±âÁØ ½Å¼³ ¹× Exenatide ÁÖ»çÁ¦ ¡¦ ÃÖºÀ±â 2014-08-27 939
142 ÇØ¿ÜÀ¯ÀÔ °ü·Ã È«¿ª¹ß»ý ´ëÀÀ¹æ¾È-³»°ú À¯ÀÇ»çÇ× Á¤¸® ÃÖºÀ±â 2014-08-27 939
141 °øÈÞÀÏ ÁøÂû·á °¡»ê½Ã ´ëü°øÈÞÀÏ Æ÷ÇÔ¿©ºÎ Àû¿ë ¾È³» ÇùÁ¶¿äû ÃÖºÀ±â 2014-08-27 1022
140 2014 Ãß°èÇмú´ëȸ »çÀüµî·ÏÀÚ ¸í´Ü(8¿ù 26ÀÏÇÑ) ±è¼º¿í 2014-08-26 816
139 2014³â Ãß°èÇмú´ëȸ µî·Ï ¹× ȸºñ ³³ºÎ ¹æ¹ý ÃÖºÀ±â 2014-08-19 958
138 ¸¸¼ºÁúȯ ÀûÁ¤¼º Æò°¡ ±âÁØÀÇ º¯°æ - 2014³â 7¿ùºÎÅÍ ÃÖºÀ±â 2014-07-29 931
137 ½ÉÆò¿ø¿¡¼­ À§ ´ëÀå ³»½Ã°æ ÀÏȸ¿ë »ý°Ë °âÀÚ ¼³¹® Á¶»ç°Ç ÃÖºÀ±â 2014-06-16 1290
136 Á¦19ȸ ´ëÇÑÀ§Àå³»½Ã°æÇÐȸ ÆòÀÇ¿øȸ ÀÚ·á ÃÖºÀ±â 2014-03-13 1176
135 2014³â ÃÑȸ ¹× Ãá°èÇмú´ëȸ ¾È³» ÃÖºÀ±â 2014-03-04 886
134 ÀÓ»óÃÊÀ½ÆÄ ÀÎÁõÀÇ ÁøÇà »çÇ× ÃÖºÀ±â 2014-02-17 1189
 1  2  3  4  5  6  7  8  9  10